Drug Approval | April 07, 2022
Lupin launches Merzee capsules in the United States
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
The new facility is scheduled to start operation in the first half of 2024
Announces pilot project for rapid, remote diagnosis of tuberculosis
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
The two-day event will showcase achievements and address issues pertaining to the industry
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
Subscribe To Our Newsletter & Stay Updated
